The COL7A1 gene helps make type VII collagen, a protein that forms tiny anchors between layers of skin. If it does not work properly, skin can blister or tear after minor rubbing, and some people also have problems in the mouth, swallowing tube, or nails. This gene plays an important role in keeping skin stable, and more disruptive variants can cause dystrophic epidermolysis bullosa, a condition marked by very fragile skin and scarring.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage activities in the body. Some provide the information needed to make proteins, which are the working parts of cells. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
COL7A1Gene function
What if the gene works
The COL7A1 gene helps make type VII collagen, a protein that forms strong anchoring fibers. These fibers help hold the outer and deeper layers of skin together and support the lining of the mouth, esophagus, and other tissues.
Risk
What if the gene does not work
Variants in the COL7A1 gene can cause dystrophic epidermolysis bullosa, where skin blisters and scars easily, sometimes with nail, mouth, or swallowing problems. Milder and more severe variants can affect how early symptoms appear and how extensive they are.
Treatment
What does that mean for your treatment
A pathogenic variant in the COL7A1 gene can make a person eligible for beremagene geperpavec, a topical gene therapy used for certain COL7A1-related wounds. It does not replace daily skin and wound care, but it can help some treated wounds close more completely.
Conditions associated with COL7A1
Gene function
What if the gene works
Your skin and many moist body surfaces stay intact because the COL7A1 gene provides instructions for type VII collagen. This protein forms fine anchoring fibers that fasten the thin outer layer to the supportive layer underneath. In daily life, that steady attachment helps skin hold up to rubbing, stretching, and ordinary movement.
The COL7A1 gene provides instructions for type VII collagen, a key part of anchoring fibers in skin. These fibers tie the outer skin layer to the deeper support layer, helping both layers move together during everyday friction.
Type VII collagen also helps stabilize the basement membrane (the thin support sheet between tissue layers). This is a central part of what the COL7A1 gene does in skin, the mouth, and the esophagus.
Inside tissues, collagen pieces made from the COL7A1 gene join into anchoring fibrils (tiny fastening fibers). These organized strands spread along the tissue border and help maintain a steady connection over wider areas.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COL7A1 gene can change how the skin anchoring protein type VII collagen is made, folded, or assembled. Some variants mainly reduce the amount of usable protein, while others shorten it or alter its shape so stable anchoring fibrils do not form well. Milder variants may leave some protein function, while more severe variants can leave little or none. This helps explain why dystrophic epidermolysis bullosa can differ in when it starts and how strongly it affects a person.
How variants are linked to conditions
Pathogenic variants in the COL7A1 gene cause dystrophic epidermolysis bullosa, a condition with fragile skin, blistering, and scarring after minor rubbing or injury. This link between COL7A1 gene variants and dystrophic epidermolysis bullosa includes dominant and recessive forms, with recessive disease often affecting more areas of the body. Some people also develop nail changes, scarring in the mouth or food pipe (esophagus), and a higher long term chance of squamous cell skin cancer.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply represent natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For COL7A1, risk is mainly shaped by whether a disease-causing gene change is inherited, so family history and whether one or both parents carry a variant matter most. Day-to-day habits do not meaningfully change the chance of having a COL7A1-related skin condition, though good skin care and early treatment can help limit complications.
Inheritance of COL7A1 variants
For families trying to understand how COL7A1 variants are inherited, the pattern depends on the specific COL7A1-related condition. Pathogenic variants in the COL7A1 gene can be passed down in an autosomal dominant or autosomal recessive way. In dominant forms, one altered copy from either parent can be enough, so each child has a 50% chance of inheriting it, and some cases begin as a new variant in the child. In recessive forms, a child inherits one altered copy from each parent, and when both parents are carriers, each pregnancy has a 25% chance of being affected.
What does my COL7A1 result mean for my family?
For COL7A1, what it means for family members depends on the exact condition linked to the result, because this gene can be tied to both dominant and recessive forms of inherited skin blistering. In some families, a parent and child may both have symptoms, while in others, parents are healthy carriers and more than one child can be affected. Close relatives may also carry the same change or have related symptoms, so family testing can help clarify who else may be affected or be a carrier.
Genetic information
Genetic testing
How you find out about variants
Testing for COL7A1 variants usually uses blood, saliva, or a cheek swab to look for changes in the COL7A1 gene. A lab reads the gene's DNA sequence and may also check for missing or extra pieces. This can show whether a disease-causing variant is present.
When should I consider getting a genetic test?
Consider testing for changes in the COL7A1 gene if someone has very fragile skin with repeated blistering, scarring, or nail changes after minor rubbing, or if these problems run in the family. Results can help confirm a form of epidermolysis bullosa, an inherited condition that makes skin tear and blister easily, and can clarify the chance of passing it on.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but what it can tell you depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while the other may notice less effect or more side effects, partly because their bodies absorb, break down, or respond to the drug differently. These inherited differences are common and are one reason medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the COL7A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have questions about medicines, side effects, or new symptoms, it is best to discuss them with your doctor so they can look at your overall health and treatment plan.
History
Throughout history, doctors described families with severe skin blistering after minor friction, long before the genetic cause was known. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became much clearer in the late 20th century. In the early 1990s, researchers identified the COL7A1 gene as the key gene linked to dystrophic epidermolysis bullosa, a major step for skin genetics. From these first observations, research expanded steadily, allowing doctors to connect different COL7A1 variants with milder or more extensive forms of the condition. This work also helped make genetic testing more precise for affected families and shaped modern diagnosis and family counseling.